Carlos Barrales-Cuenca
Granada, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Impact of Hidradenitis Suppurativa on Major Life-Changing Decisions: A Cross-Sectional Study.
Journal: Indian journal of dermatology
Published: September 08, 2025
Accessibility as a Key Factor in the Clinical Evolution and Therapeutic Management of Patients With Hidradenitis Suppurativa.
Journal: Actas dermo-sifiliograficas
Published: May 02, 2025
Oral Supplementation with a New Hyaluronic Acid Matrix Ingredient Improves Skin Brightness, Hydration, Smoothness, and Roughness: Results from a Randomized, Double-Blinded, Placebo-Controlled Study.
Journal: Dermatology and therapy
Published: April 03, 2025
The Microbiome in Hidradenitis Suppurativa Tunnels: A Systematic Review.
Journal: International journal of dermatology
Published: January 21, 2025
Real World Evidence of Secukinumab and Bimekizumab in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis.
Journal: Actas dermo-sifiliograficas
Published: January 14, 2025
Severity and Therapeutic Decisions Based on Lesion Location in Patients With Hidradenitis Suppurativa.
Journal: International journal of dermatology
Published: December 01, 2024
Ultrasound-guided Percutaneous Galvanic Current Compared to Ultrasound-guided Intralesional Corticosteroid Infiltration in Tunnels of Hidradenitis Suppurativa.
Journal: Actas dermo-sifiliograficas
Published: November 27, 2024
Implementation of a Multidisciplinary Medical-Surgical Consultation in Hidradenitis Suppurativa Improves Patient Journey and Time to Surgery.
Journal: Dermatology (Basel, Switzerland)
Published: October 02, 2024
Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study.
Journal: Actas dermo-sifiliograficas
Published: July 30, 2024
Therapeutic burden in hidradenitis suppurativa: a cross-sectional study of 557 patients.
Journal: International journal of dermatology
Published: July 14, 2024
Insights into the Window of Opportunity and Outcome Measures in Patients with Moderate to Severe Hidradenitis Suppurativa Treated with Secukinumab: A Real-World Study.
Journal: Dermatology and therapy
Published: May 07, 2024
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study.
Journal: The Australasian journal of dermatology
Published: February 05, 2024
Last Updated: 09/26/2026